Related Experiment Video
Updated: Jan 28, 2026

Author Spotlight: Photodynamic Therapy as a Novel Approach to Induce Petite Colonies in Drug-Resistant Candida for Antifungal Research
Published on: March 29, 2024
In vitro interactions of crocin with fluconazole against Candida isolates
Narges Aslani1, Mohammad Taghi Hedayati2,3, Mojtaba Nabili4
1Infectious and Tropical Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Background And Purpose:
The incidence of invasive fungal infections has been increased in recent years. The growing use of azole drugs for prophylactic and therapeutic purposes has resulted in the gradual emergence of azole-resistant species. Accordingly, the introduction of a new strategy to improve the management of Candida infections is an urgent need. Regarding this, the present study was performed to evaluate the antifungal activities of crocin (Cro) alone and in combination with fluconazole.
Materials And Methods:
This study was conducted on 50 clinical isolates of four different Candida species. The identity of the isolates was confirmed using the internal transcribed spacer identification system. The interactions of Cro with fluconazole were investigated using a microdilution checkerboard method based on the Clinical and Laboratory Standards Institute reference technique with 96-well microtiter plates. Furthermore, the assessment of the interaction of drug combinations was accomplished using the fractional inhibitory concentration index (FICI) based on the Loewe additivity theory.
Results:
According to the results, Cro alone showed a relatively high MIC50 value (1 g/ml) against Candida species. Our results demonstrated indifferent interactions between Cro and fluconazole with a FICI range of 0.5-4 against Candida strains.
Conclusion:
The high MIC value for Cro against Candida species indicated its failure to show appropriate antifungal activity against this species. The MIC of this agent was not significantly reduced even by the addition of fluconazole. Therefore, other mechanisms which are not related to the mechanism of azole drugs are involved at high concentration of Cro.
Insights
Crocin showed high minimum inhibitory concentration (MIC) values against Candida species, indicating limited antifungal activity. Combining crocin with fluconazole did not significantly enhance its efficacy against these fungal infections.
Area of Science:
- Mycology
- Pharmacology
- Infectious Diseases
Background:
- Rising incidence of invasive fungal infections.
- Emergence of azole-resistant fungal species due to widespread azole drug use.
- Urgent need for novel strategies to manage Candida infections.
Purpose of the Study:
- Evaluate the antifungal activity of crocin (Cro) alone.
- Assess the combined effect of crocin and fluconazole against Candida species.
Main Methods:
- Utilized 50 clinical isolates of four Candida species.
- Confirmed isolate identity using the internal transcribed spacer identification system.
- Employed microdilution checkerboard method and fractional inhibitory concentration index (FICI) to determine drug interactions.
Main Results:
- Crocin exhibited a high MIC50 value (1 µg/ml) against Candida species.
- Interactions between crocin and fluconazole were largely indifferent, with FICI ranging from 0.5 to 4.
- Fluconazole did not significantly reduce the MIC of crocin.
Conclusions:
- Crocin demonstrates insufficient antifungal activity against Candida species at the tested concentrations.
- The combination of crocin and fluconazole does not offer synergistic antifungal effects.
- High concentrations of crocin may involve mechanisms independent of azole drug pathways.
Related Concept Videos
Predator-Prey Interactions
Van der Waals Interactions
piRNA - Piwi-interacting RNAs
Drug-Receptor Interactions
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Gene-Environment Interactions
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

